Improving the cost-effectiveness of photographic screening for diabetic macular oedema

a prospective, multi-centre, UK study

Gordon Prescott, Peter Sharp, Keith Goatman, Graham Scotland, Alan Fleming, Sam Philip, Roger Staff, Cynthia Santiago, Shyamanga Borooah, Deborah Broadbent, Victor Chong, Paul Dodson, Simon Harding, Graham Leese, Roly Megaw, Caroline Styles, Ken Swa, Helen Wharton, John Olson*

*Corresponding author for this work

Research output: Contribution to journalArticle

19 Citations (Scopus)
6 Downloads (Pure)

Abstract

Background/aims Retinal screening programmes in England and Scotland have similar photographic grading schemes for background (non-proliferative) and proliferative diabetic retinopathy, but diverge over maculopathy. We looked for the most cost-effective method of identifying diabetic macular oedema from retinal photographs including the role of automated grading and optical coherence tomography, a technology that directly visualises oedema.

Methods Patients from seven UK centres were recruited. The following features in at least one eye were required for enrolment: microaneurysms/dot haemorrhages or blot haemorrhages within one disc diameter, or exudates within one or two disc diameters of the centre of the macula. Subjects had optical coherence tomography and digital photography. Manual and automated grading schemes were evaluated. Costs and QALYs were modelled using microsimulation techniques.

Results 3540 patients were recruited, 3170 were analysed. For diabetic macular oedema, England's scheme had a sensitivity of 72.6% and specificity of 66.8%; Scotland's had a sensitivity of 59.5% and specificity of 79.0%. When applying a ceiling ratio of 30 000 per quality adjusted life years (QALY) gained, Scotland's scheme was preferred. Assuming automated grading could be implemented without increasing grading costs, automation produced a greater number of QALYS for a lower cost than England's scheme, but was not cost effective, at the study's operating point, compared with Scotland's. The addition of optical coherence tomography, to each scheme, resulted in cost savings without reducing health benefits.

Conclusions Retinal screening programmes in the UK should reconsider the screening pathway to make best use of existing and new technologies.

Original languageEnglish
Pages (from-to)1042-1049
Number of pages8
JournalBritish Journal of Ophthalmology
Volume98
Issue number8
Early online date28 Mar 2014
DOIs
Publication statusPublished - Aug 2014

Keywords

  • retinopathy
  • photocoagulation
  • program
  • adult
  • aged
  • automation
  • cost-benefit-analysis
  • diabetic retinopathy
  • female
  • Great Britain
  • humans
  • macular edema
  • male
  • mass screening
  • middle aged
  • photography
  • prospective studies
  • quality improvement
  • quality-adjusted life years
  • sensitivity and specificity
  • tomography, optical coherence

Cite this

Improving the cost-effectiveness of photographic screening for diabetic macular oedema : a prospective, multi-centre, UK study. / Prescott, Gordon; Sharp, Peter; Goatman, Keith; Scotland, Graham; Fleming, Alan; Philip, Sam; Staff, Roger; Santiago, Cynthia; Borooah, Shyamanga; Broadbent, Deborah; Chong, Victor; Dodson, Paul; Harding, Simon; Leese, Graham; Megaw, Roly; Styles, Caroline; Swa, Ken; Wharton, Helen; Olson, John.

In: British Journal of Ophthalmology, Vol. 98, No. 8, 08.2014, p. 1042-1049.

Research output: Contribution to journalArticle

Prescott, Gordon ; Sharp, Peter ; Goatman, Keith ; Scotland, Graham ; Fleming, Alan ; Philip, Sam ; Staff, Roger ; Santiago, Cynthia ; Borooah, Shyamanga ; Broadbent, Deborah ; Chong, Victor ; Dodson, Paul ; Harding, Simon ; Leese, Graham ; Megaw, Roly ; Styles, Caroline ; Swa, Ken ; Wharton, Helen ; Olson, John. / Improving the cost-effectiveness of photographic screening for diabetic macular oedema : a prospective, multi-centre, UK study. In: British Journal of Ophthalmology. 2014 ; Vol. 98, No. 8. pp. 1042-1049.
@article{1a593a092056438aba67f88073787482,
title = "Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study",
abstract = "Background/aims Retinal screening programmes in England and Scotland have similar photographic grading schemes for background (non-proliferative) and proliferative diabetic retinopathy, but diverge over maculopathy. We looked for the most cost-effective method of identifying diabetic macular oedema from retinal photographs including the role of automated grading and optical coherence tomography, a technology that directly visualises oedema.Methods Patients from seven UK centres were recruited. The following features in at least one eye were required for enrolment: microaneurysms/dot haemorrhages or blot haemorrhages within one disc diameter, or exudates within one or two disc diameters of the centre of the macula. Subjects had optical coherence tomography and digital photography. Manual and automated grading schemes were evaluated. Costs and QALYs were modelled using microsimulation techniques.Results 3540 patients were recruited, 3170 were analysed. For diabetic macular oedema, England's scheme had a sensitivity of 72.6{\%} and specificity of 66.8{\%}; Scotland's had a sensitivity of 59.5{\%} and specificity of 79.0{\%}. When applying a ceiling ratio of 30 000 per quality adjusted life years (QALY) gained, Scotland's scheme was preferred. Assuming automated grading could be implemented without increasing grading costs, automation produced a greater number of QALYS for a lower cost than England's scheme, but was not cost effective, at the study's operating point, compared with Scotland's. The addition of optical coherence tomography, to each scheme, resulted in cost savings without reducing health benefits.Conclusions Retinal screening programmes in the UK should reconsider the screening pathway to make best use of existing and new technologies.",
keywords = "retinopathy, photocoagulation, program, adult, aged, automation, cost-benefit-analysis, diabetic retinopathy, female, Great Britain, humans, macular edema, male, mass screening, middle aged, photography, prospective studies, quality improvement, quality-adjusted life years, sensitivity and specificity, tomography, optical coherence",
author = "Gordon Prescott and Peter Sharp and Keith Goatman and Graham Scotland and Alan Fleming and Sam Philip and Roger Staff and Cynthia Santiago and Shyamanga Borooah and Deborah Broadbent and Victor Chong and Paul Dodson and Simon Harding and Graham Leese and Roly Megaw and Caroline Styles and Ken Swa and Helen Wharton and John Olson",
year = "2014",
month = "8",
doi = "10.1136/bjophthalmol-2013-304338",
language = "English",
volume = "98",
pages = "1042--1049",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "8",

}

TY - JOUR

T1 - Improving the cost-effectiveness of photographic screening for diabetic macular oedema

T2 - a prospective, multi-centre, UK study

AU - Prescott, Gordon

AU - Sharp, Peter

AU - Goatman, Keith

AU - Scotland, Graham

AU - Fleming, Alan

AU - Philip, Sam

AU - Staff, Roger

AU - Santiago, Cynthia

AU - Borooah, Shyamanga

AU - Broadbent, Deborah

AU - Chong, Victor

AU - Dodson, Paul

AU - Harding, Simon

AU - Leese, Graham

AU - Megaw, Roly

AU - Styles, Caroline

AU - Swa, Ken

AU - Wharton, Helen

AU - Olson, John

PY - 2014/8

Y1 - 2014/8

N2 - Background/aims Retinal screening programmes in England and Scotland have similar photographic grading schemes for background (non-proliferative) and proliferative diabetic retinopathy, but diverge over maculopathy. We looked for the most cost-effective method of identifying diabetic macular oedema from retinal photographs including the role of automated grading and optical coherence tomography, a technology that directly visualises oedema.Methods Patients from seven UK centres were recruited. The following features in at least one eye were required for enrolment: microaneurysms/dot haemorrhages or blot haemorrhages within one disc diameter, or exudates within one or two disc diameters of the centre of the macula. Subjects had optical coherence tomography and digital photography. Manual and automated grading schemes were evaluated. Costs and QALYs were modelled using microsimulation techniques.Results 3540 patients were recruited, 3170 were analysed. For diabetic macular oedema, England's scheme had a sensitivity of 72.6% and specificity of 66.8%; Scotland's had a sensitivity of 59.5% and specificity of 79.0%. When applying a ceiling ratio of 30 000 per quality adjusted life years (QALY) gained, Scotland's scheme was preferred. Assuming automated grading could be implemented without increasing grading costs, automation produced a greater number of QALYS for a lower cost than England's scheme, but was not cost effective, at the study's operating point, compared with Scotland's. The addition of optical coherence tomography, to each scheme, resulted in cost savings without reducing health benefits.Conclusions Retinal screening programmes in the UK should reconsider the screening pathway to make best use of existing and new technologies.

AB - Background/aims Retinal screening programmes in England and Scotland have similar photographic grading schemes for background (non-proliferative) and proliferative diabetic retinopathy, but diverge over maculopathy. We looked for the most cost-effective method of identifying diabetic macular oedema from retinal photographs including the role of automated grading and optical coherence tomography, a technology that directly visualises oedema.Methods Patients from seven UK centres were recruited. The following features in at least one eye were required for enrolment: microaneurysms/dot haemorrhages or blot haemorrhages within one disc diameter, or exudates within one or two disc diameters of the centre of the macula. Subjects had optical coherence tomography and digital photography. Manual and automated grading schemes were evaluated. Costs and QALYs were modelled using microsimulation techniques.Results 3540 patients were recruited, 3170 were analysed. For diabetic macular oedema, England's scheme had a sensitivity of 72.6% and specificity of 66.8%; Scotland's had a sensitivity of 59.5% and specificity of 79.0%. When applying a ceiling ratio of 30 000 per quality adjusted life years (QALY) gained, Scotland's scheme was preferred. Assuming automated grading could be implemented without increasing grading costs, automation produced a greater number of QALYS for a lower cost than England's scheme, but was not cost effective, at the study's operating point, compared with Scotland's. The addition of optical coherence tomography, to each scheme, resulted in cost savings without reducing health benefits.Conclusions Retinal screening programmes in the UK should reconsider the screening pathway to make best use of existing and new technologies.

KW - retinopathy

KW - photocoagulation

KW - program

KW - adult

KW - aged

KW - automation

KW - cost-benefit-analysis

KW - diabetic retinopathy

KW - female

KW - Great Britain

KW - humans

KW - macular edema

KW - male

KW - mass screening

KW - middle aged

KW - photography

KW - prospective studies

KW - quality improvement

KW - quality-adjusted life years

KW - sensitivity and specificity

KW - tomography, optical coherence

U2 - 10.1136/bjophthalmol-2013-304338

DO - 10.1136/bjophthalmol-2013-304338

M3 - Article

VL - 98

SP - 1042

EP - 1049

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 8

ER -